3M’s Intelligent Control Inhaler wins CPhI award

The Intelligent Control Inhaler from 3M Drug Delivery Systems has won the drug delivery devices category of the CPhI Pharma Awards.

According to CPhI, the inhaler was recognized “for its approach to addressing patient adherence and competence in Asthma and COPD patients” and is “an intuitive, fully integrated device delivering accurate doses to patients, whilst providing on-screen instructions for use and feedback to the patient and health care provider via an app.”

CPhI Worldwide added the drug delivery devices category to its awards for the first time in 2016. A single dose nasal applicator from Harro Höfliger was also named a finalist in this category.

3MDDS officially launched the Intelligent Control Inhaler in April 2016, showing off the connected device at the RDD meeting.

Read the CPhI press release.

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK